The Diagnostic and Prognostic Value of Brain Natriuretic Peptide and Aminoterminal (nt)-pro Brain Natriuretic Peptide
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
511-525
Author(s):
Thomas Weber, Johann Auer and Bernd Eber
Leptin, Immune Responses and Autoimmune Disease. Perspectives on the Use of Leptin Antagonists
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
539-548
Author(s):
F. Peelman, H. Iserentant, S. Eyckerman, L. Zabeau and J. Tavernier
Protein Kinase C Isozyme Selective Peptides - A Current View of What they Tell Us About Location and Function of Isozymes in the Heart
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
549-559
Author(s):
Livia C. Hool
Subject Index to Volume 4
Journal:
Current Cancer Drug Targets
Volume:
5
Page:
73-84
Author(s):
Bentham Science Publishers
Signal Transduction Pathways and Transcription Factors as Therapeutic Targets in Inflammatory Disease: Towards Innovative Antirheumatic Therapy
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
581-611
Author(s):
Sander W. Tas, Philip H.J. Remans, Kris A. Reedquist and Paul P. Tak
An Integrated Platform for Bio-Analysis and Drug Delivery
Journal:
Current Pharmaceutical Biotechnology
Volume:
6
Page:
57-64
Author(s):
S. Amer and W. Badawy
Effects of Erythropoietin on Brain Function
Journal:
Current Pharmaceutical Biotechnology
Volume:
6
Page:
65-79
Author(s):
W. Jelkmann
Application of Sterylglucoside-Containing Particles for Drug Delivery
Journal:
Current Pharmaceutical Biotechnology
Volume:
6
Page:
81-93
Author(s):
Yoshie Maitani, Koji Nakamura and Kumi Kawano
Computer Aided Drug Design Strategies Used in the Discovery of Fructose 1, 6-Bisphosphatase Inhibitors
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
283-294
Author(s):
M. Rami Reddy and Mark D. Erion
Thalidomide as an Immunotherapeutic Agent: The Effects on Neutrophil- Mediated Inflammation
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
395-401
Author(s):
Kozo Yasui, Norimoto Kobayashi, Takashi Yamazaki and Kazunaga Agematsu